Early detection of cancer and precancerous conditions improves patient survival. This study will identify a set of peptides and proteins (P/P) in serum associated with hepatocellular carcinoma (HCC). To achieve this goal, we developed enrichment of the low molecular weight (LMW) serum fraction for matrix assisted laser desorption ionization-time of flight (MALD1-TOF/TOF) mass spectrometric (MS) identification of biomarkers. This method allows high-throughput screening of a population as well as identification of the peptides of interest by TOF/TOF sequencing. We tested the biomarker discovery method on a pilot set of HCC cases and matched controls from our unique study of HCC in Egypt, a country with an epidemic of hepatitis C viral infection. The pilot-study identified a set of six peptides that predict HCC with 96% prediction accuracy. In this study, we propose to expand the project and focus on identification of peptides associated with malignant conversion of liver cirrhosis. Our goal is to identify biomarkers that would improve early detection of HCC in this high-risk group and track the natural progression of chronic viral hepatitis to cancer. We will cross validate our ongoing study in Egypt with a study of HCC in the US population;verify peptide- identification by MALDI-TOF/TOF sequencing, complementary liquid chromatography/mass spectrometry, synthesis of peptides standards, and immunodepletion;develop improved methods for quantification of the peptides;and test performance of the biomarker-candidates. Defining clinically applicable biomarkers of early-stage cancer has potentially far-reaching consequences for disease management and patient health. The biomarkers could be used to screen high risk populations for early signs of disease;to design and test new chemoprevention strategies;and to follow disease progression after treatment. Identification of the P/P is expected to generate new hypotheses for targeted disease management.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA115625-04
Application #
7774370
Study Section
Cancer Biomarkers Study Section (CBSS)
Program Officer
Wagner, Paul D
Project Start
2007-02-15
Project End
2012-01-31
Budget Start
2010-02-01
Budget End
2012-01-31
Support Year
4
Fiscal Year
2010
Total Cost
$346,147
Indirect Cost
Name
Georgetown University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
An, Yanming; Goldman, Radoslav (2013) Analysis of peptides by denaturing ultrafiltration and LC-MALDI-TOF-MS. Methods Mol Biol 1023:13-9
Pompach, Petr; Brnakova, Zuzana; Sanda, Miloslav et al. (2013) Site-specific glycoforms of haptoglobin in liver cirrhosis and hepatocellular carcinoma. Mol Cell Proteomics 12:1281-93
Ressom, Habtom W; Xiao, Jun Feng; Tuli, Leepika et al. (2012) Utilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosis. Anal Chim Acta 743:90-100
Mazumder, Raja; Morampudi, Krishna Sudeep; Motwani, Mona et al. (2012) Proteome-wide analysis of single-nucleotide variations in the N-glycosylation sequon of human genes. PLoS One 7:e36212
Isailovic, Dragan; Plasencia, Manolo D; Gaye, Maissa M et al. (2012) Delineating diseases by IMS-MS profiling of serum N-linked glycans. J Proteome Res 11:576-85
Bekesova, S; Kosti, O; Chandler, K B et al. (2012) N-glycans in liver-secreted and immunoglogulin-derived protein fractions. J Proteomics 75:2216-24
Pompach, Petr; Chandler, Kevin B; Lan, Renny et al. (2012) Semi-automated identification of N-Glycopeptides by hydrophilic interaction chromatography, nano-reverse-phase LC-MS/MS, and glycan database search. J Proteome Res 11:1728-40
Kosti, O; Goldman, L; Saha, D T et al. (2011) DNA damage phenotype and prostate cancer risk. Mutat Res 719:41-6
Kosti, Ourania; Xu, Xia; Veenstra, Timothy D et al. (2011) Urinary estrogen metabolites and prostate cancer risk: a pilot study. Prostate 71:507-16
An, Yanming; Bekesova, Slavka; Edwards, Nathan et al. (2010) Peptides in low molecular weight fraction of serum associated with hepatocellular carcinoma. Dis Markers 29:11-20

Showing the most recent 10 out of 18 publications